BIOVENTUS INC - A (BVS) Stock Fundamental Analysis

NASDAQ:BVS • US09075A1088

8.66 USD
+0.08 (+0.93%)
At close: Feb 23, 2026
8.66 USD
0 (0%)
After Hours: 2/23/2026, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

BVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. BVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BVS was profitable.
  • In the past year BVS had a positive cash flow from operations.
  • In multiple years BVS reported negative net income over the last 5 years.
  • BVS had a positive operating cash flow in 4 of the past 5 years.
BVS Yearly Net Income VS EBIT VS OCF VS FCFBVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • BVS has a better Return On Assets (1.11%) than 74.59% of its industry peers.
  • BVS has a Return On Equity of 4.71%. This is in the better half of the industry: BVS outperforms 76.22% of its industry peers.
  • BVS has a Return On Invested Capital of 6.62%. This is in the better half of the industry: BVS outperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA 1.11%
ROE 4.71%
ROIC 6.62%
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
BVS Yearly ROA, ROE, ROICBVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With a decent Profit Margin value of 1.39%, BVS is doing good in the industry, outperforming 73.51% of the companies in the same industry.
  • BVS has a better Operating Margin (8.03%) than 74.59% of its industry peers.
  • In the last couple of years the Operating Margin of BVS has declined.
  • BVS has a Gross Margin of 67.76%. This is in the better half of the industry: BVS outperforms 73.51% of its industry peers.
  • In the last couple of years the Gross Margin of BVS has declined.
Industry RankSector Rank
OM 8.03%
PM (TTM) 1.39%
GM 67.76%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
BVS Yearly Profit, Operating, Gross MarginsBVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
  • Compared to 1 year ago, BVS has more shares outstanding
  • The number of shares outstanding for BVS has been increased compared to 5 years ago.
  • The debt/assets ratio for BVS has been reduced compared to a year ago.
BVS Yearly Shares OutstandingBVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BVS Yearly Total Debt VS Total AssetsBVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • BVS has an Altman-Z score of 1.32. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
  • BVS has a Altman-Z score of 1.32. This is comparable to the rest of the industry: BVS outperforms 54.59% of its industry peers.
  • The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.22, BVS is in the better half of the industry, outperforming 76.76% of the companies in the same industry.
  • A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
  • BVS has a worse Debt to Equity ratio (1.93) than 81.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 6.22
Altman-Z 1.32
ROIC/WACC0.61
WACC10.87%
BVS Yearly LT Debt VS Equity VS FCFBVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
  • BVS has a worse Current ratio (1.74) than 68.11% of its industry peers.
  • A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
  • The Quick ratio of BVS (1.14) is worse than 71.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.14
BVS Yearly Current Assets VS Current LiabilitesBVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
  • The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
  • The Revenue has been growing slightly by 1.58% in the past year.
  • Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.45% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.25% on average over the next years.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5Y17.45%
Revenue Next Year0.15%
Revenue Next 2Y3.42%
Revenue Next 3Y4.42%
Revenue Next 5Y5.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BVS Yearly Revenue VS EstimatesBVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 200M 400M 600M
BVS Yearly EPS VS EstimatesBVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.68, which indicates a correct valuation of BVS.
  • 88.65% of the companies in the same industry are more expensive than BVS, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, BVS is valued a bit cheaper.
  • BVS is valuated reasonably with a Price/Forward Earnings ratio of 10.79.
  • 94.59% of the companies in the same industry are more expensive than BVS, based on the Price/Forward Earnings ratio.
  • BVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.75.
Industry RankSector Rank
PE 14.68
Fwd PE 10.79
BVS Price Earnings VS Forward Price EarningsBVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 89.73% of the companies in the same industry are more expensive than BVS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 96.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.4
EV/EBITDA 10.76
BVS Per share dataBVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BVS's earnings are expected to grow with 25.05% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BVS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BIOVENTUS INC - A

NASDAQ:BVS (2/23/2026, 8:00:03 PM)

After market: 8.66 0 (0%)

8.66

+0.08 (+0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)03-17
Inst Owners74.45%
Inst Owner Change2.12%
Ins Owners2.5%
Ins Owner Change0.55%
Market Cap716.70M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (76.67%)
Short Float %2.62%
Short Ratio5.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 14.68
Fwd PE 10.79
P/S 1.27
P/FCF 13.4
P/OCF 12.79
P/B 4.31
P/tB N/A
EV/EBITDA 10.76
EPS(TTM)0.59
EY6.81%
EPS(NY)0.8
Fwd EY9.27%
FCF(TTM)0.65
FCFY7.46%
OCF(TTM)0.68
OCFY7.82%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.35
PEG (5Y)N/A
Graham Number5.16
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 4.71%
ROCE 8.38%
ROIC 6.62%
ROICexc 7.18%
ROICexgc 31.69%
OM 8.03%
PM (TTM) 1.39%
GM 67.76%
FCFM 9.48%
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 6.22
Debt/EBITDA 3.44
Cap/Depr 5.36%
Cap/Sales 0.45%
Interest Coverage 250
Cash Conversion 60.26%
Profit Quality 683.69%
Current Ratio 1.74
Quick Ratio 1.14
Altman-Z 1.32
F-Score8
WACC10.87%
ROIC/WACC0.61
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5Y17.45%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.15%
Revenue Next 2Y3.42%
Revenue Next 3Y4.42%
Revenue Next 5Y5.25%
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.72%
EBIT Next 5Y10.4%
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%

BIOVENTUS INC - A / BVS FAQ

Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?

ChartMill assigns a fundamental rating of 4 / 10 to BVS.


What is the valuation status for BVS stock?

ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.


Can you provide the profitability details for BIOVENTUS INC - A?

BIOVENTUS INC - A (BVS) has a profitability rating of 4 / 10.


What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 14.68 and the Price/Book (PB) ratio is 4.31.


What is the financial health of BIOVENTUS INC - A (BVS) stock?

The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.